Prior rituximab administration is associated with reduced rate of acute GVHD after in vivo T-cell depleted transplantation in lymphoma patients

R. Crocchiolo, L. Castagna, J. El-Cheikh, A. Helvig, S. Fürst, C. Faucher, A. Vazquez, A. Granata, D. Coso, R. Bouabdallah, D. Blaise

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Prior rituximab administration is associated with reduced rate of acute GVHD after in vivo T-cell depleted transplantation in lymphoma patients'. Together they form a unique fingerprint.

Medicine & Life Sciences